News from J&J, Teva and Amarantus – People on the move
in-PharmaTechnologist.com presents its weekly round-up of the latest new appoitnments within the world of pharma and biopharma including news from J&J, Teva and Amarantus.
Archives for November 12, 2012
Boehringer set to make E.coli for clinical trials
Molecular Partners has contracted Boehringer Ingelheim to produce a range of highly potent molecules for its clinical pipeline.
Restart of Singapore plant project unlikely to affect Lonza deal, says Novartis
Novartis says the decision to reactivate plans for a biotechnology plant in Singapore is unlikely to affect its deal with Lonza.
Italy’s AIFA lifts ban on Novartis flu vaccines
Italian regulators have lifted a temporary ban on two Novartis flu vaccines in which high levels of protein aggregates were detected.